Objectives and Scope
The BMC aims to support the development of innovative healthcare products, technologies and processes. Such solutions can include (but are not limited to) those focused on:
The aim of Early and Late Stage awards is to create a data package that is sufficient to support the subsequent testing of products or process in a clinical setting or other relevant environment.
Support is available for any life science sector or discipline, including (but not limited to):
The total funding allocated to Early and Late Stage awards is £7m.
Projects should have costs of between £250k and £4m, with durations of at least 1 year. All projects must be led by a UK-based SME or RTO, SMEs can work alone or collaborate but RTOs must collaborate with at least 2 SMEs.
Successful applicants can receive funding:
Large organisations are not eligible for funding.
Research organisations can receive up to 100% funding, which is capped at 50% of total eligible project costs and is shared between such organisations if more than one participates.
Applications: noon, 03/04/2019
Invitations to interview: 10/05/2019